Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 48.41
+2.16 (4.67%)
At close: Jul 10, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 1.79 billion as of July 10, 2026. Its market cap has decreased by -57.17% in one year.
Market Cap
1.79B
Enterprise Value
2.86B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
48.41
Market Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 1.79B, an increase of 24,708.76%. That is a compound annual growth rate of 20.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.79B | -13.23% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.41B |
| Ambalal Sarabhai Enterprises | 2.38B |
| Kerala Ayurveda | 2.15B |
| Sat Kartar Life | 2.13B |
| Coral Laboratories | 2.10B |
| Sanjivani Paranteral | 1.76B |
| Accretion Pharmaceuticals | 1.75B |
| Parnax Lab | 1.67B |